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The ability of the fetal rat to respond to interleukin l/3 (ILlB) by expressing xl-acid glycoprotein (AGP) was investigated. Eight and 20 h after 
injection of 7 ng ILl/I into 19-day fetuses, liver AGP mRNA increased by a factor of 66 and 82 respectively, while serum AGP levels increased 
by a factor of 3 and 5. Similar treatment of the mothers altered in the fetuses neither AGP serum levels nor the amount of liver AGP mRNA. 
The induction of AGP gene expression in the fetal liver in response to ILlg was similar to that observed in the adult liver. These results demonstrate 
that at day 19 the fetal rat liver has aquired a mature acute-phase system. 
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1. INTRODUCTION 2. MATERIALS AND 
A single injection of terpentine to the fetal rat elicits 
an inflammatory response involving a number of 
positive and negative acute-phase proteins [l]. This 
suggests that the activation mechanism of cells leading 
to the release of inflammatory mediators [2] and to the 
induction of the liver acute-phase response system in 
the fetal rat is at least partly mature. 
2.1. Treatment 
Interleukin 1 (ILl), tumor necrosis factor LY (TNFa) 
and interleukin 6 (IL6) are considered to be the major 
mediators of the acute-phase response in adult rats [3]. 
As the liver response is strongly dependent on (a) the 
hepatic cell type and (b) the acute-phase protein [4], we 
sought to determine whether the fetal liver is equally 
responsive to cytokines and with the same spectrum as 
the adult liver. 
Sprague-Dawley rats (Charles River France, strain CD) were hous- 
ed at 21-24°C under a 14 h-10 h light-dark cycle with laboratory 
chow &JAR) and tap water ad libitum. Human recombinant Ills (a 
gift from Dr Boussaut, Rhane-Poulenc, France) had a specific activi- 
ty of 5 x 10’ units/mg and contained 0.91 ng/mg of endotoxin. ILl@ 
was dissolved in sterile RPM1 1640 containing 5% fetal calf serum. 
Five-week-old male or female rats received an intravenous injection 
of either 0.2 or 1 cg ILla in 5OOpl or the solvent alone (control 
animals). Pregnant rats were injected at day 19 of pregnancy, the day 
after mating being taken as day 0. In another experiment, following 
laparatomy of mothers under ether anesthesia, the 19-day-old fetuses 
received a single dorsal S.C. injection of either ILl@ (7 or 35 ng in 
10 ~1) or the solvent alone (10 ~1). The whole operation was perform- 
ed in less than 15 min. Eight or 20 h after injection, blood was col- 
lected after decapitation of adults and fetuses and centrifuged at 
4000 rpm at 4OC. Pooled sera from 2 or 3 fetuses and serum from the 
corresponding mothers were stocked at -30°C until assay. 
The pattern of protein concentrations in fetal rat 
blood is quite different from that in adult: 
cu2-macroglobulin and al-fetoprotein levels are very 
high in the former whereas they are nearly undetectable 
in the latter. Conversely, al-acid glycoprotein (AGP, 
or orosomucoid) and albumin show lower levels in 
fetuses than in adults [ 11. 
For RNA extraction, liver specimens (500 mg) from pregnant rats 
and fetuses were immediately frozen in sterile tubes maintained for 
a few minutes in a dry-ice/ethanol bath and then stored at -80°C un- 
til use. 
2.2. AGP assay and statistical assessment 
In this report, we show that ILl,8 acts as an acute- 
phase modulator in the rat fetus by increasing liver 
AGP mRNA and serum AGP levels. 
Serum AGP levels were determined using a sensitive nzyme-linked 
immunosorbent assay (ELISA) developed in our laboratory [5]. 
Values are given as mean f SEM. Data were analyzed using the Mann 
and Whitney U-test. 
2.3. Isolation of RNA and Northern blot analysis 
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Total cellular RNA was extracted from frozen pieces of rat liver by 
the guanidine isothiocyanate/cesium chloride method [6] using a 
Beckman SW 55 rotor for 16 h at 30000 rpm. Heat-denatured RNA 
samples were run as previously described [7] in 1.2% agarose gels 
containing 2.2 M formaldehyde for 16 h at 2 V/cm. Blotting of RNA 
onto Biodyne A nylon membranes (Pall Ultrafine Filtration Corpora- 
tion) was done by Northern capillary transfer for about 36 h. After 
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Effect of IL@ injection 
Table I 
to fetuses on serum levels of al-acid 
glycoprotein 
Time after 
injection 
Control 
fetuses 
Treated fetuses 
RPM1 ILl@ (7 ng) ILla (35 ng) 
8h 4.75 f 0.35 4.5 * 0.7 14.4 f 3.5* - 
20 h 7.22 + 1.1 9.2 f 1.5 45.1 f 1.8* 42.7 i 1.8* 
Fetuses were treated at day 19 of fetal life. Serum concentrations are 
given as mg/l. Means (2 SEM) of assays of 3-9 pools of 2-3 sera. 
* P < 0.05 
Table II 
Effect of ILlfi injection to pregnant rats on serum levels of al-acid 
glycoprotein in mothers and fetuses 
Treatment Pregnant rats Fetuses 
RPM1 66i 21 7.22 i 1.1 
ILla (0.2 Bg) 257 * 179* 6.5 f 2.5 
ILV (1 P8) 518 f 254* 6.2 f 0.6 
Pregnant rats were treated at day 19 of gestation. Serum was 
collected 20 h after treatment. Serum AGP concentrations are given 
as mg/l. Means (f SEM) of 3-9 assays. * P < 0.05 
transfer, the filters were air-dried and baked at 8O*C for 2 h, then 
prehybridized for at least 3 h at 42°C in 50% formamide, 5 x SSC, 
5 x Denhardt solution, 0.1% SDS, 50 mM sodium phosphate, pH 
6.5, and 250&m] denatured herring sperm DNA. A recombinant 
plasmid containing a 740 base-pair insert encoding rat AGP was used 
to probe Northern blots. The RR1 strain of Escherichin coli contain- 
ing the recombinant plasmid was obtained from J.M. Taylor [8]. 
Plasmid DNA and the AGP gene insert were Iabelled by nick- 
translation to a specific activity of 1.6 x 10s cpm/pg DNA using 
[cr-32P]dCTP. Hybridization proceeded for 24-48 h at 42°C under 
the same conditions as for prehybridization. Filters were washed 
under high stringency several times at room temperature in large 
volumes of 2 x SSC and 0.1% SDS, and for about 1 h at 50°C in four 
changes of 0.1 x SSC and 0.1 To SDS. The wet filters, enclosed in 
Saran film were exposed to hyperfilm MP (Amersham) at -80°C us- 
ing Lightning Plus inte~if~ng screens (Dupont Cronex). 
2.4. Dot-biot analysis 
AGP mRNA was quantified by dot-blot analysis using a Bio-dot 
apparatus (Bio-Rad). Using serial half-dilutions from 20 fig to 313 ng 
total cellular RNA was spotted onto Hybond-N+ nylon membranes 
which were processed as recommended by the membrane supplier 
(~ersham), and in the same conditions as for Northern blots. 
Autoradiographies were scanned by means of photometric den- 
sitometry (Sebia). 
3. RESULTS 
As shown in Table I, the injection of 7 ng ILla into 
fetuses induced 3- and 5-fold increases in serum AGP 
levels after 8 h and 20 h, respectively. Higher doses of 
ILl@ (35 ng) did not lead to further increases. When 
ILlp was administered to only half the fetuses of a 
single pregnant rat, no increase in serum AGP levels 
was observed in the untreated fetuses (treated: 42.7 +- 
1.8 mgll, untreated: 7.7 f 1.25 mg/I). In addition, 
maternal serum AGP levels were not altered by fetal 
treatment (results not shown). Inversely, the injection 
of ILIfl (0.2 pg or 1 cg) into mothers did not affect 
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Fig. 1. Northern blot analysis of AGP mRNA from control and IL&9 treated pregnant rats, and from their fetuses directly treated or not. Owing 
to the very low levels of serum AGP in fetuses (Table I), 4Opg total liver RNA were loaded per lane (g-15) instead of 20~~ for the RNA of 
the mothers (lanes I-8). After a single injection of RPM1 to control mothers, their liver mRNAs were analyzed at 3 h (lane 2), 20 h (lane 1), 
and liver mRNA from their fetuses at 8 h (lane 9). After a single injection of fLl@ (0.2~4g) to the mothers, their liver mRNAs were analyzed 
at 3 h (lane 3), 8 h (lane 4) and 20 h (lane 6). With a higher dose of ILlfl(1 pg) liver mRNAs were analyzed at 8 h (lane 5), 20 h (lanes 7, 8), 
and the liver mRNA from their fetuses at 20 h (lanes 10, 11). Only two bands of premessenger mRNA could be detected for the fetuses which 
had not directly received ILl@ (Ianes 9-11). After a direct injection of RPM1 to control fetuses, their liver mRNAs were analyzed at 8 h (lane 
12) and 20 h (lane 14). Lanes 13 and 15 correspond to liver mRNA from fetuses 8 h and 20 h respectively after a direct treatment with 7 ng IL1/3. 
Only trace amounts of mature AGP mRNA could be detected in control fetuses (lanes 12, 14) in comparison with fetuses which had received 
ILl@ (lanes 13, 15). The size of mature and premessenger mRNAs were estimated with ‘Raoul I’ (lane a) molecular weight marker (from 
Appligene, France) which hybridizes with pBR322 plasmid DNA, and also with 28s and 185 rRNA after methylene blue staining of the Northern 
blot (lane b). 
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AGP levels in fetal serum, despite a 4- or 8-fold in- 
crease in maternal values (Table II). The injection of 
1 ,ug ILlp to adult male and adult non-pregnant female 
rats resulted in a 6- to 8-fold increase in serum AGP 
levels (not shown). 
Rat liver AGP mRNA was evidenced specifically by 
hybridization of total cellular RNA with the AGP 
cDNA probe. Fig. 1 shows the results of the Northern 
blot analysis of 15 RNA samples from control (slots 
1,2) and treated pregnant rats (slots 3-8) and from 
their fetuses directly treated (slots 13, 15) or untreated 
(slots 9-11) with ILIP. When ILlp (7 ng) was directly 
injected to the fetuses, mature AGP mRNA was strong- 
ly expressed 8 h and 20 h after injection (slots 13, 15) 
compared to only trace amounts in solvent-treated con- 
trols (slots 12, 14). In contrast, ILl,& administered to 
the mothers did not induce any effect in their fetuses 
since no hybridization signal was observed (slots 10, 
11). However, it is interesting to note that 2 or 3 bands 
of premessenger RNAs (size = 1850, 2650 and 3500 
bases) were detected in both control and treated preg- 
nant rats as well as in their fetuses, even when no 
mature mRNAs are expressed (slots 9-11). 
Densitometric scanning of the RNA samples analyz- 
ed by dot-blot (Fig. 2) showed that fetal liver AGP 
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Fig. 2. Autoradiography of dot hybridization of AGP cDNA to the 
mRNA contained in the 15 RNA samples analyzed in Fig. 1. 
Columns a-g correspond to serial half-dilutions from 2O/~g (a) to 
0.313 pg (g). Mean integration values of dots giving proportional 
densities, estimated for 1 pg of total cellular RNA, were as follows: 
116 (I), 140 (2), 233 (3), 146 (4). 1960 (5). 2.544 (6), 2724 (7), 7048 (8), 
1.3 (9), 1 (10). 0.6 (ll), 4 (i2), 450 (13), 6 (14), 435 (15). 
mRNA was increased 66- and 82-fold, respectively, 8 h 
and 20 h after direct treatment of the fetuses with 7 ng 
ILlp. Maternal AGP liver mRNAs were increased 20- 
to 60-fold 20 h after treatment with 0.2 ag and 1 ,ug 
IL&!?, respectively. As seen on the Northern blot 
(Fig. 1, slots 10, ll), the trace amounts of hybrids 
detected on dot-blots (Fig. 2, lines 10, 11) for the 
fetuses which were not directly treated with ILL&, cor- 
respond to high molecular weight premessenger RNAs 
(size = 1850 and 2650 bases). 
4. DISCUSSION 
In this work, hepatic stimulation by ILlP was studied 
without concomitant treatment with dexamethasone 
which is known to synergize the effect of cytokines [4]. 
In order to obtain a maximal effect of ILlfl, ex- 
periments were performed at day 19 of gestation when 
the amount of corticosterone in fetal blood is highest 
[9], and when there is a simult~~us appearance of 
hepatocyte glucoco~icoid receptor activity [IO]. The 
amounts of ILl@ administered to the fetus were chosen 
as a function of fetal weight, compared to doses nor- 
mally administered to adult rats. 
The major finding of this study is that AGP gene ex- 
pression is induced in the fetal rat liver in response to 
ILl,& treatment. The maximal increase in fetal liver 
AGP mRNA (82-fold) was of the same order of 
magnitude as that observed after the injection of an op- 
timal dose of ILl@ into adult rats @O-fold). Our results 
are in agreement with the finding that terpentine injec- 
tion leads to a 45- to 90-fold increase in adult rat liver 
AGP mRNA [8,1 l] but contrast with the results of De 
Jong et al. [12], who observed only a 2.9-fold increase 
in cytoplasmic AGP mRNA in adult rat liver following 
the injection of ILIP. The 5-fold increase observed here 
in fetal serum AGP levels following ILlp treatment is 
similar to the 4-fold increase obtained 48 h after the in- 
jection of terpentine to l&day fetuses [l]. 
Our finding strongly suggests that in the fetal rat, 
ILlP is the major inducer of AGP gene expression. In- 
deed it has been clearly shown that in adult rat primary 
hepatocyte cultures and in rat hepatoma cells, IL1 is a 
stronger inducer of AGP mRNA than are IL6 and 
TNFcv [4]. However, it cannot be excluded that ILl,& 
might have an additional effect on AGP synthesis 
through the induction of TNFa! and IL6 [13]. Taken 
together, these results indicate that at day 19, the fetal 
rat liver is able to respond to ILl@ in a similar way to 
the adult liver, and is insensitive to an inflammatory 
stimulus given to the mother. 
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